Ganoderma lucidum Prevents Cisplatin-Induced Nephrotoxicity through Inhibition of Epidermal Growth Factor Receptor Signaling and Autophagy-Mediated Apoptosis
Open Access
- 6 July 2020
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-13
Abstract
Background. Cisplatin (cis-diaminedichloroplatinum, CDDP) is a broad-spectrum antineoplastic agent. However, CDDP has been blamed for its nephrotoxicity, which is the main dose-limiting adverse effect. Ganoderma lucidum (GL), a medicinal mushroom, has antioxidant and inflammatory activities. Therefore, this study is aimed at finding out the potential nephroprotection of GL against CDDP-induced nephrotoxicity in rats and the possible molecular mechanisms including the EGFR downstream signaling, apoptosis, and autophagy. Methods. Rats were given GL (500 mg/kg) for 10 days and a single injection of CDDP (12 mg/kg, i.p). Results. Nephrotoxicity was evidenced by a significant increase in renal indices and oxidative stress markers. Additionally, CDDP showed a plethora of inflammatory and apoptotic responses as evidenced by a profound increase of HMGB-1, NF-κB, and caspase-3 expressions, whereas administration of GL significantly improved all these indices as well as the histopathological insults. Renal expression of EGFR showed a similar trend after GL administration. Furthermore, activation of autophagy protein, LC3 II, was found to be involved in GL-mediated nephroprotection correlated with the downregulation of apoptotic signaling, caspase-3 and terminal deoxynucleotidyl transferase (TDT) renal expressions. Conclusion. These results suggest that GL might have improved CDDP-induced nephrotoxicity through antioxidant, anti-inflammatory, and autophagy-mediated apoptosis mechanisms and that inhibition of EGFR signaling might be involved in nephroprotection.Keywords
Funding Information
- Princess Nourah Bint Abdulrahman University
This publication has 73 references indexed in Scilit:
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic FunctionsPLOS ONE, 2013
- Assessment of cisplatin-induced kidney injury using an integrated rodent platformToxicology and Applied Pharmacology, 2013
- Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in ratsAmerican Journal of Physiology-Renal Physiology, 2012
- Cisplatin in breast cancer treatment in BRCA1 carriersHereditary Cancer in Clinical Practice, 2012
- Chemotherapy in advanced bladder cancer: current status and futureJournal of Hematology & Oncology, 2011
- Mechanisms of Cisplatin NephrotoxicityToxins, 2010
- Induction Chemotherapy for Head and Neck Cancer: Recent DataThe Oncologist, 2010
- Prevention of cisplatin induced nephrotoxicity by terpenes isolated from Ganoderma lucidum occurring in Southern Parts of IndiaExperimental and Toxicologic Pathology, 2009
- Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cellsKidney International, 2008
- HIF Activation Protects From Acute Kidney InjuryJournal of the American Society of Nephrology, 2008